Home/Filings/4/0001140361-24-010240
4//SEC Filing

Guiheen Lawrence P. 4

Accession 0001140361-24-010240

CIK 0001368514other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 9:00 PM ET

Size

8.2 KB

Accession

0001140361-24-010240

Insider Transaction Report

Form 4
Period: 2024-02-26
Transactions
  • Award

    Stock Option (right to buy)

    2024-02-26+37,54137,541 total
    Exercise: $5.40Exp: 2034-02-26Common Stock (37,541 underlying)
  • Award

    Common Stock

    2024-02-26+24,040153,941 total
Holdings
  • Common Stock

    (indirect: See footnote)
    1,000
Footnotes (4)
  • [F1]These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.
  • [F2]Includes, as of the transaction date, (i) 24,040 RSUs granted on February 26, 2024 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 25,815 RSUs granted on March 6, 2023 which will vest in full on March 6, 2024; and (iii) 104,086 shares of common stock owned by the reporting person.
  • [F3]These shares are owned by the Guiheen Trust, of which Mr. Guiheen serves as a joint trustee.
  • [F4]The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Issuer

ADMA BIOLOGICS, INC.

CIK 0001368514

Entity typeother

Related Parties

1
  • filerCIK 0001554353

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 9:00 PM ET
Size
8.2 KB